Madrigal Pharmaceuticals

PA · United States · Reporting entity ID 100001448154

Total reported 2019–2025

$57.9M

#152 of 2,960 reporting companies — 0.1% of all reported industry payments

$20.1M in general payments across 95,810 records, plus $37.8M in research funding across 5,787 records.

How it breaks down

General payments $20,088,730

Research funding $37,771,098

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.